Inventiva Revenue

In the year 2025, Inventiva had annual revenue of 4.48M EUR, down -51.26%. Inventiva had revenue of 29.00K in the half year ending December 31, 2025, a decrease of -99.81%.

Revenue

4.48M

Revenue Growth

-51.26%

P/S Ratio

138.25

Revenue / Employee

92.62K

Employees

Market Cap

934.68M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.48M	-4.72M	-51.26%
Dec 31, 2024	9.20M	-8.28M	-47.37%
Dec 31, 2023	17.48M	5.30M	43.50%
Dec 31, 2022	12.18M	7.99M	190.39%
Dec 31, 2021	4.19M	3.82M	1,027.42%
Dec 31, 2020	372.00K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Valneva SE	174.66M
Cellectis	67.79M
Genfit	65.43M
Nanobiotix	32.59M
MedinCell	32.44M
Innate Pharma	9.01M
Transgene	7.21M
Sensorion	5.81M

Revenue Rankings

Inventiva News

1 day ago - Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor - GlobeNewsWire
15 days ago - Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F - GlobeNewsWire
24 days ago - Inventiva reports 2025 full year results and provides a business update - GlobeNewsWire
4 weeks ago - Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results - GlobeNewsWire
2 months ago - Inventiva reports preliminary 2025¹ fiscal year financial results - GlobeNewsWire
2 months ago - Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
3 months ago - Biotech Inventiva's 50% surge shows investor optimism over liver disease drug - Reuters
5 months ago - Inventiva reports 2025 Third Quarter Financial Information¹ - GlobeNewsWire

More News